论文部分内容阅读
Background Nicorandil, an opener of ATP-sensitive K+ channels, was used to treat angina in patients with coronary artery disease.In this study, we aim to investigate the cardioprotective effects of single oral dose of nicorandil in patients undergoing selective percutaneous coronary intervention (PCI).